3 Middle Eastern Penny Stocks With At Least US$100M Market Cap
As global trade tensions continue to impact markets, many Gulf indices have seen declines, reflecting broader economic uncertainties. Despite these challenges, the Middle Eastern market remains a fertile ground for investment opportunities, particularly in the realm of penny stocks. While often overlooked and considered outdated by some, penny stocks represent smaller or newer companies that can offer substantial growth potential when backed by strong financials. In this article, we explore three such stocks that stand out for their promising prospects and robust balance sheets.
Name
Share Price
Market Cap
Financial Health Rating
Thob Al Aseel (SASE:4012)
SAR3.85
SAR1.54B
★★★★★★
Keir International (SASE:9542)
SAR3.85
SAR462M
★★★★★☆
Alarum Technologies (TASE:ALAR)
₪2.243
₪155.53M
★★★★★★
Oil Refineries (TASE:ORL)
₪0.90
₪2.8B
★★★★★☆
Tgi Infrastructures (TASE:TGI)
₪2.183
₪162.29M
★★★★★★
Union Properties (DFM:UPP)
AED0.519
AED2.23B
★★★★☆☆
Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC)
AED0.738
AED431.86M
★★★★★★
Al Ansari Financial Services PJSC (DFM:ALANSARI)
AED0.973
AED7.27B
★★★★☆☆
E7 Group PJSC (ADX:E7)
AED1.03
AED2.06B
★★★★★★
Dubai Investments PJSC (DFM:DIC)
AED2.36
AED9.99B
★★★★☆☆
Click here to see the full list of 98 stocks from our Middle Eastern Penny Stocks screener.
We're going to check out a few of the best picks from our screener tool.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Bank Of Sharjah P.J.S.C. operates as a provider of commercial and investment banking products and services in the United Arab Emirates, with a market capitalization of AED2.82 billion.
Operations: The company's revenue is derived from two primary segments: Commercial Banking, contributing AED315.01 million, and Investment Banking, generating AED262.69 million.
Market Cap: AED2.82B
Bank Of Sharjah P.J.S.C. has recently turned profitable, reporting a net income of AED 385 million for 2024 compared to a loss the previous year. The bank's price-to-earnings ratio of 7.3x suggests it is valued below the broader AE market average, potentially appealing to value investors. Despite having an appropriate Loans to Deposits ratio (75%) and primarily low-risk funding sources, the bank faces challenges with high bad loans at 8.1%. The management team is relatively new with an average tenure of just 0.3 years, which may impact strategic continuity and execution moving forward.
Click here to discover the nuances of Bank Of Sharjah P.J.S.C with our detailed analytical financial health report.
Evaluate Bank Of Sharjah P.J.S.C's historical performance by accessing our past performance report.
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Amanat Holdings PJSC, with a market cap of AED2.67 billion, invests in companies and enterprises within the education and healthcare sectors both in the United Arab Emirates and internationally.
Operations: The company's revenue is derived from AED432.26 million in the education sector and AED363.84 million in healthcare.
Market Cap: AED2.67B
Amanat Holdings PJSC, with a market cap of AED2.67 billion, has shown significant improvement in financial performance, reporting AED 796.1 million in sales and a net income of AED 115.84 million for 2024 compared to a loss the previous year. The company's earnings growth of 191.4% over the past year outpaced industry averages despite a historical decline over five years. Although its Return on Equity is low at 6.2%, Amanat maintains strong short-term asset coverage and interest payment capabilities while managing debt effectively with more cash than total debt, though dividend sustainability remains an area for concern given free cash flow constraints.
Take a closer look at Amanat Holdings PJSC's potential here in our financial health report.
Examine Amanat Holdings PJSC's past performance report to understand how it has performed in prior years.
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Novolog (Pharm-Up 1966) Ltd is a healthcare services provider in Israel with a market cap of ₪730.50 million.
Operations: No revenue segments have been reported for this healthcare services provider in Israel.
Market Cap: ₪730.5M
Novolog (Pharm-Up 1966) Ltd, with a market cap of ₪730.50 million, has transitioned to profitability this year, reporting sales of ₪2.02 billion for 2024 and a net income of ₪39.54 million compared to a loss the previous year. Despite its low Return on Equity at 10.7%, the company benefits from being debt-free and having experienced management and board members with average tenures of over four years. While short-term liabilities slightly exceed assets by ₪100 million, high-quality earnings and stable weekly volatility underscore its financial resilience amidst challenges in dividend coverage by earnings.
Navigate through the intricacies of Novolog (Pharm-Up 1966) with our comprehensive balance sheet health report here.
Assess Novolog (Pharm-Up 1966)'s previous results with our detailed historical performance reports.
Take a closer look at our Middle Eastern Penny Stocks list of 98 companies by clicking here.
Looking For Alternative Opportunities? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ADX:BOS DFM:AMANAT and TASE:NVLG.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
a day ago
- Newsweek
How Trump Middle East Hotel Planned For 2028 Will Look
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Donald Trump's signature brand has announced plans for a new hotel to be built in Oman as part of the company's expansion in the Middle East. The Trump Organization has partnered with Oman's state-run tourism department, the Omran Group, to design and build the Trump International Oman Hotel before the end of the decade. Newsweek contacted the Trump Organization for more information via email. The Context The Trump Organization is investing heavily in Middle Eastern construction over the next decade, with major construction projects in Saudi Arabia and the UAE. By 2031, the company hopes that three new structures will be operating in the region, which is billing itself as a new hub for tourism and international investment in order to diversify the regional economy away from oil exports. A rendering of the hotel entrance of the Trump Interational Oman Hotel. A rendering of the hotel entrance of the Trump Interational Oman Hotel. Dar Global What To Know The new hotel, designed by luxury real estate developer Dar Global, will be built in Oman's capital, Muscat. Like many of the Trump Organization's other buildings, the hotel will borrow heavily from its namesake's reputation for opulence, using the same white-gold color scheme present in Trump Tower, New York and the two planned towers in Saudi Arabia and the UAE. Rendered images of the project's future released by Dar Global show that the hotel will house a swimming pool, a nightclub, and a viewing deck for the Gulf of Oman, as well as an international golf course, all Trump-branded. A rendering of a hanging bedroom in the Trump Interational Oman Hotel. A rendering of a hanging bedroom in the Trump Interational Oman Hotel. Dar Global One of the most ambitious parts of the hotel, if built correctly, will be a series of hanging suites that face the coast, with wall-to-ceiling windows for views. The hotel has a reported price tag of $500 million, with construction expected to be finished by the end of 2028. However, the first phase of building work is set to be done by 2027. What People Are Saying In a statement seen by Newsweek, the Omran Group said: "Oman is quickly becoming one of the most prominent commercial and cultural hubs in the region and is rapidly becoming a prime investment destination due to its attractive benefits. "From its favorable tax environment and its strategic location as a gateway to the Middle East and Africa, Oman offers countless opportunities for businesses to grow and thrive." A rendering of the loby of the Trump Interational Oman Hotel. A rendering of the loby of the Trump Interational Oman Hotel. Dar Global Eric Trump, who manages the Trump Organization with his brother Donald Jr., said in December: "This collaboration embodies our shared vision of creating landmark developments that exude luxury, quality, and sophistication. Together with Dar Global, we are setting new benchmarks for excellence, aiming to meet the demand for iconic properties in key markets." What Happens Next Dar Global and the Trump Organization have said that the hotel will be fully constructed by December 2028.
Miami Herald
2 days ago
- Miami Herald
Gucci, YSL owner sends blunt message about tariff threats
I bought my first pair of Saint Laurent (YSL) heels when I was 25. They were all black patent leather in the iconic Tribute style, with crisscross straps and a sky-high platform that made absolutely no sense and every kind of sense at the same time. I can't remember exactly why, but I had some reason to celebrate (or so I told myself), and I couldn't resist the rush of slipping those shoes on in the YSL store at Copley in Boston. They were bold. A little aggressive. And completely, unapologetically French. Related: Popular luxury brand takes a massive leap of faith in risky move That moment wasn't just about fashion - it was about owning something that felt like power. Putting them on was like flipping a switch: confidence, elegance, a little bit of edge. Luxury brands like YSL know exactly what they're selling. Sure, there's craftsmanship and quality, but really, it's culture. A story. An idea that something made in France or Italy is worth paying a premium. So when presidents start throwing around threats of tariffs and urging companies to move production closer to home, that idea gets tested. But Kering (PPRUY) , the company behind Gucci, YSL, and Bottega Veneta, just made it clear: it has no intention of budging. Image source: Sorbis/Shutterstock On the Q1 2025 earnings call, Kering CEO François-Henri Pinault made one thing clear: the company won't be moving its production out of Europe in response to U.S. tariffs. "Most of our brands we are producing in Italy and in France, and this is part of the promise that we bring through our products, through our heritage, to the consumer," he told investors. He went even further, adding, "We are selling part of our culture, being an Italian culture or a French culture. So we have no plan of producing to counter the tariff. It makes no sense." Related: Luxury outerwear brand avoids tariffs as rivals try to exit China His comments came just days after President Donald Trump signaled that sweeping new tariffs on goods from the European Union were imminent, calling the EU's trade actions "an atrocity." Pinault said the company already operates in large global markets (like China) where import duties are standard, and he emphasized that adjusting its entire supply chain would dilute the very value proposition luxury buyers are paying for. Still, Kering isn't ignoring the issue. Pinault acknowledged the company may have to rethink pricing strategy if the tariffs go into effect. Tariffs aren't the only problem on Kering's plate. In its latest results, the group reported a 14% drop in revenue for the first quarter of 2025, totaling €3.9 billion. Gucci continues to struggle. The brand brought in €1.6 billion in Q1 2025, down 24% year-over-year. Sales fell sharply across both its retail and wholesale channels. Meanwhile, YSL posted €679 million in Q1 revenue, down 8%, with some resilience in European and Middle Eastern markets. Kering closed 25 stores globally during the quarter, and although Bottega Veneta (up 4%) and its beauty and eyewear segments saw growth, the group's overall trajectory remains challenged. Pinault addressed the issue, stating, "We are increasing our vigilance to weather the macroeconomic headwinds our industry faces." The company also recently offloaded its stake in The Mall Luxury Outlets and entered a joint venture for three Parisian real estate assets, moves that signal a tighter focus on its core business and brand strategy. Kering's message - heritage over haste - is one not all luxury players may be able to afford. But if it pulls through, it'll be because it stood by elegance, even when tariffs made shortcuts tempting. Related: Versace, Michael Kors, Jimmy Choo stumble hard The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
Yahoo
2 days ago
- Yahoo
Global's Top Penny Stocks To Watch In June 2025
Global markets have been navigating a complex landscape, with U.S. stocks showing resilience amid trade policy uncertainties and inflation easing to its slowest pace in four years. Against this backdrop, investors might find opportunities in penny stocks—an investment area that, despite its somewhat outdated name, remains relevant for those seeking growth potential in smaller or newer companies. These stocks can offer surprising value when backed by strong financial health, presenting a mix of value and growth that larger firms might overlook. Name Share Price Market Cap Financial Health Rating EZZ Life Science Holdings (ASX:EZZ) A$1.50 A$71.94M ★★★★★★ Lever Style (SEHK:1346) HK$1.14 HK$725.59M ★★★★★★ Foresight Group Holdings (LSE:FSG) £3.96 £445.67M ★★★★★★ Angler Gaming (NGM:ANGL) SEK3.61 SEK270.7M ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.44 SGD178.33M ★★★★★☆ Southern Cross Electrical Engineering (ASX:SXE) A$1.67 A$453.46M ★★★★★★ Tasmea (ASX:TEA) A$3.08 A$716.16M ★★★★★☆ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.31 SGD9.09B ★★★★★☆ Bosideng International Holdings (SEHK:3998) HK$4.39 HK$50.15B ★★★★★★ Croma Security Solutions Group (AIM:CSSG) £0.86 £11.84M ★★★★★★ Click here to see the full list of 5,587 stocks from our Global Penny Stocks screener. We'll examine a selection from our screener results. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Shenzhen Asia Link Technology Development Co., Ltd. operates in the technology sector with a market capitalization of CN¥1.66 billion. Operations: No specific revenue segments have been reported for this company. Market Cap: CN¥1.66B Shenzhen Asia Link Technology Development Co., Ltd. is navigating the penny stock landscape with a market cap of CN¥1.66 billion, demonstrating resilience through its substantial cash runway exceeding three years at current free cash flow levels. Despite being unprofitable with negative return on equity, it has reduced losses by 24.7% annually over five years and boasts a seasoned management team and board of directors. Recent earnings reveal improved financial performance, with Q1 2025 revenues rising to CN¥104.95 million from CN¥83.29 million year-over-year, indicating potential growth amidst existing short-term liabilities challenges and stable debt levels relative to assets. Unlock comprehensive insights into our analysis of Shenzhen Asia Link Technology DevelopmentLtd stock in this financial health report. Gain insights into Shenzhen Asia Link Technology DevelopmentLtd's past trends and performance with our report on the company's historical track record. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Guizhou Bailing Group Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development, production, and sale of traditional Chinese medicine products, with a market cap of CN¥5.65 billion. Operations: No specific revenue segments have been reported for the company. Market Cap: CN¥5.65B Guizhou Bailing Group Pharmaceutical Co., Ltd. is navigating financial challenges with a market cap of CN¥5.65 billion, having recently turned profitable despite a significant earnings decline over five years. The company reported Q1 2025 revenues of CN¥760.59 million, down from the previous year, and net income of CN¥24.17 million. Its debt management shows improvement with a reduced debt-to-equity ratio and satisfactory net debt levels supported by operating cash flow covering 23% of its debt. However, short-term liabilities match short-term assets, posing liquidity concerns amidst stable weekly volatility and experienced management oversight. Jump into the full analysis health report here for a deeper understanding of Guizhou Bailing Group Pharmaceutical. Examine Guizhou Bailing Group Pharmaceutical's past performance report to understand how it has performed in prior years. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Hainan RuiZe New Building Material Co., Ltd operates in China, focusing on the production and sale of commercial concrete and municipal sanitation services, with a market cap of CN¥3.98 billion. Operations: The company generates revenue primarily from its operations in China, amounting to CN¥1.23 billion. Market Cap: CN¥3.98B Hainan RuiZe New Building Material Co., Ltd, with a market cap of CN¥3.98 billion, faces financial challenges as it remains unprofitable with increasing losses over the past five years. Despite reporting sales of CN¥1.28 billion for 2024, revenue declined from the previous year, and net losses persisted at CN¥241.53 million. The company's high net debt to equity ratio of 175.8% raises concerns about its financial leverage, although it maintains a stable cash runway due to positive free cash flow growth. Additionally, short-term assets exceed both short and long-term liabilities, providing some balance sheet strength amidst volatility stability. Navigate through the intricacies of Hainan RuiZe New Building MaterialLtd with our comprehensive balance sheet health report here. Learn about Hainan RuiZe New Building MaterialLtd's historical performance here. Take a closer look at our Global Penny Stocks list of 5,587 companies by clicking here. Contemplating Other Strategies? Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SZSE:002316 SZSE:002424 and SZSE:002596. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
